GRID2IP
Delphilin
Also known as: GRD2I_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A4D2P6
- Gene
- GRID2IP
- Ensembl
- ENSG00000215045
- Chromosome
- 7
- Canonical length
- 1211 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Glutamate receptor delta-2 (GRID2; MIM 602368) is predominantly expressed at parallel fiber-Purkinje cell postsynapses and plays crucial roles in synaptogenesis and synaptic plasticity. GRID2IP1 interacts with GRID2 and may control GRID2 signaling in Purkinje cells (Matsuda et al., 2006 [PubMed 16835239]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
1211 residues, UniProt reviewed canonical sequence.
>A4D2P6|GRID2IP
1 MATTATPATN QGWPEDFGFR LGGSGPCFVL EVAKGSSAHA GGLRPGDQIL EVEGLAVGGL
61 SRERLVRLAR RCPRVPPSLG VLPAPDGGPG PGSGPAAPTT VLRAPRCGRG LALGRELLRL
121 AGRKRPDAVH RERRRKAQEF SRKVDEILGD QPTAKEQVFA ALKQFAAEQR VDDLVWTLTL
181 ALPREACGPL LDNLRIFIPK KHRARFDEVV SQGLLGKLCR ARRAQGAQRL RRSRSEERPE
241 RLLVSTRASA PPRRPDEPPP RRASLLVGGL AGPGGARRTV RVYKGNKSFG FTLRGHGPVW
301 IESVLPGSPA DNAALKSGDR ILFLNGLDMR NCSHDKVVSM LQGSGAMPTL VVEEGLVPFA
361 SDSDSLDSPN PSSALTSLQW VAEILPSSIR VQGRTFSQQL EHLLTPPERY GVCRALESFF
421 QHRNIDTLIV DVYPVLDTPA KQVLWQFIYQ LLTYEEQELC QEKIACFLGY TAMTAEPEPE
481 LDLESEPTPE PQPRSSLRAS SMCRRSLRSQ GLEAGLSCGP SECPEMPLPL IPGERQAGDG
541 TSLPETPNPK MMSAVYAELE SRLNSSFKGK MGTVSKSRAS PPGPSPAVTT GPRTLSGVSW
601 PSERLLPSPC YHPLCSGGLA SPSSSESHPY ASLDSSRAPS PQPGPGPICP DSPPSPDPTR
661 PPSRRKLFTF SHPVRSRDTD RFLDVLSEQL GPRVTIVDDF LTPENDYEEM SFHDDQGSFV
721 TNERSSASDC ISSSEEGSSL TYSSISDHIP PPPLSPPPPP PLPFHDAKPS SRSSDGSRGP
781 AQALAKPLTQ LSHPVPPPPP PPLPPPVPCA PPMLSRGLGH RRSETSHMSV KRLRWEQVEN
841 SEGTIWGQLG EDSDYDKLSD MVKYLDLELH FGTQKPAKPV PGPEPFRKKE VVEILSHKKA
901 YNTSILLAHL KLSPAELRQV LMSMEPRRLE PAHLAQLLLF APDADEEQRY QAFREAPGRL
961 SEPDQFVLQM LSVPEYKTRL RSLHFQATLQ EKTEEIRGSL ECLRQASLEL KNSRKLAKIL
1021 EFVLAMGNYL NDGQPKTNKT TGFKINFLTE LNSTKTVDGK STFLHILAKS LSQHFPELLG
1081 FAQDLPTVPL AAKVNQRALT SDLADLHGTI SEIQDACQSI SPSSEDKFAM VMSSFLETAQ
1141 PALRALDGLQ REAMEELGKA LAFFGEDSKA TTSEAFFGIF AEFMSKFERA LSDLQAGEGL
1201 RSSGMVSPLA WLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRID2IP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 2.4 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 2.4 nTPM
- pituitary gland: 0.9 nTPM
- skin: 0.6 nTPM
- basal ganglia: 0.5 nTPM
- pancreas: 0.5 nTPM
- retina: 0.5 nTPM
Single-cell type
- tuft cells: 46 nCPM
- gonadotrophs: 22 nCPM
- epicardial cells: 21 nCPM
- retinal ganglion cells: 19 nCPM
- hematopoietic stem cells: 12 nCPM
- undifferentiated spermatogonia: 12 nCPM
Immune cell
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- thalamus: 73 nTPM
- cerebellum: 27 nTPM
- midbrain: 25 nTPM
- hypothalamus: 19 nTPM
- amygdala: 19 nTPM
- basal ganglia: 19 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.12
- gnomAD missense Z
- 1.07
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- long-term synaptic depression
- regulation of postsynaptic cytosolic calcium ion concentration
- regulation of postsynaptic membrane neurotransmitter receptor levels
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRID2IP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRID2IP as an antibody target. Whether an autoantibody or antibody against GRID2IP could matter depends on whether native GRID2IP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRID2IP is annotated at the cell surface, where native GRID2IP is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GRID2IP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...